Platelet-Rich Plasma in Androgenetic Alopecia.

Androgenetic alopecia PDO RCF RPM hair transplant male pattern baldness platelet-rich plasma platelet-rich plasma guidelines preparation recommendations regenerative medicine threads

Journal

Indian dermatology online journal
ISSN: 2229-5178
Titre abrégé: Indian Dermatol Online J
Pays: India
ID NLM: 101586880

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 25 05 2021
revised: 13 06 2021
accepted: 21 07 2021
entrez: 3 1 2022
pubmed: 4 1 2022
medline: 4 1 2022
Statut: epublish

Résumé

The goal of these recommendations is to provide a framework to practitioners for implementing useful, evidence-based recommendations for the preparation of platelet-rich plasma (PRP) and its use in androgenetic alopecia (AGA). The Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) assigned the task of preparing these recommendations to its taskforce on PRP. A comprehensive literature search was done in the English language on the PRP across multiple databases. The grade of evidence and strength of recommendation were evaluated on the GRADE (Grading of Recommendation, Assessment, Development, and Evaluation) framework. A draft of clinical recommendations was developed on the best available evidence, which was also scrutinized and critically evaluated by the IADVL Academy of Dermatology. Based on the inputs received, the final consensus statement was prepared. A total of 30 articles (meta-analyses, prospective and retrospective studies, reviews [including chapters in books], and case series) were critically evaluated, and the evidence thus gathered was used in the preparation of these recommendations. This expert group recommends use of manual double-spin method for the preparation of PRP for AGA. Minimum three to five sessions of PRP are recommended for AGA with a gap of 1 month between the two sessions. Patients with Grade II to V Norwood Hamilton classification of AGA are the ideal subset for PRP. A total of 5 to 7 mL of PRP and 0.05 to 0.1 mL/cm

Identifiants

pubmed: 34976879
doi: 10.4103/idoj.idoj_328_21
pii: IDOJ-12-31
pmc: PMC8664169
doi:

Types de publication

Journal Article

Langues

eng

Pagination

S31-S40

Informations de copyright

Copyright: © 2021 Indian Dermatology Online Journal.

Déclaration de conflit d'intérêts

There are no conflicts of interest.

Références

J Cosmet Dermatol. 2020 Jul;19(7):1738-1744
pubmed: 31789457
Aesthet Surg J. 2017 Jan;37(1):71-83
pubmed: 27530764
Stem Cells Transl Med. 2015 Nov;4(11):1317-23
pubmed: 26400925
Dent Today. 2017 Apr;36(4):74-6
pubmed: 29235312
Clin Exp Rheumatol. 2008 Sep-Oct;26(5):910-3
pubmed: 19032827
J Cutan Aesthet Surg. 2014 Oct-Dec;7(4):213-9
pubmed: 25722600
Clin Oral Investig. 2020 Aug;24(8):2819-2828
pubmed: 31788748
Nature. 2007 May 17;447(7142):316-20
pubmed: 17507982
BMJ. 2004 Jun 19;328(7454):1490
pubmed: 15205295
Skin Res Technol. 2019 Sep;25(5):701-711
pubmed: 31206839
Clin Oral Implants Res. 2006 Apr;17(2):212-9
pubmed: 16584418
Int J Oral Maxillofac Implants. 1999 Jul-Aug;14(4):529-35
pubmed: 10453668
Indian J Dermatol Venereol Leprol. 2017 May-Jun;83(3):412
pubmed: 27679404
J Cosmet Dermatol. 2020 Apr;19(4):827-835
pubmed: 31452328
Int J Trichology. 2014 Jan;6(1):35-6
pubmed: 25114455
Dermatol Surg. 2016 Dec;42(12):1335-1339
pubmed: 27631460
Dermatol Surg. 2016 Apr;42(4):491-7
pubmed: 27035501
Blood Transfus. 2008 Jan;6(1):12-7
pubmed: 18661919
Implant Dent. 2001;10(4):225-8
pubmed: 11813662
Dermatol Ther. 2019 May;32(3):e12897
pubmed: 30963686
Int J Mol Sci. 2020 Apr 13;21(8):
pubmed: 32295047
Biomed Res Int. 2016;2016:6591717
pubmed: 27672658
Skin Appendage Disord. 2018 Jan;4(1):18-24
pubmed: 29457008
Sci Rep. 2017 Apr 25;7(1):1125
pubmed: 28442778
J Cosmet Laser Ther. 2016 Dec;18(8):452-455
pubmed: 27593381
Clin Oral Investig. 2016 Dec;20(9):2353-2360
pubmed: 26809431
Trends Biotechnol. 2009 Mar;27(3):158-67
pubmed: 19187989
Asian J Transfus Sci. 2015 Jul-Dec;9(2):159-62
pubmed: 26420936
Dermatol Surg. 2011 Dec;37(12):1721-9
pubmed: 21883644
Int J Trichology. 2018 Jan-Feb;10(1):1-10
pubmed: 29440850
J Clin Invest. 1969 Jun;48(6):1073-82
pubmed: 5771188
Stem Cell Investig. 2017 Jul 18;4:64
pubmed: 28815175
Med J Armed Forces India. 2021 Jul;77(3):355-362
pubmed: 34305291
J Cosmet Dermatol. 2021 May;20(5):1421-1426
pubmed: 32996229
Eur Spine J. 2004 Oct;13 Suppl 1:S102-6
pubmed: 15221571
Indian J Dermatol Venereol Leprol. 2017 Jan-Feb;83(1):47-54
pubmed: 27549867
Cells. 2019 May 16;8(5):
pubmed: 31100937
J Invest Dermatol. 1996 Mar;106(3):391-6
pubmed: 8648166
Int J Clin Exp Pathol. 2017 Dec 01;10(12):11703-11709
pubmed: 31966530
J Eur Acad Dermatol Venereol. 2018 Jan;32(1):11-22
pubmed: 29178529
J Cosmet Dermatol. 2018 Oct;17(5):666-671
pubmed: 29790267
Stem Cell Res Ther. 2015 Sep 15;6:173
pubmed: 26373929
Dermatol Surg. 2018 Sep;44(9):1183-1190
pubmed: 30045107
J Cosmet Dermatol. 2019 Feb;18(1):59-64
pubmed: 29707872
BMJ Open Sport Exerc Med. 2016 Feb 4;2(1):e000060
pubmed: 27900152
Biomed Res Int. 2014;2014:760709
pubmed: 24883322
Clin Drug Investig. 2019 Sep;39(9):865-872
pubmed: 31228018
J Invest Dermatol. 2013 Jan;133(1):31-41
pubmed: 22810306
Indian J Dermatol. 2019 Sep-Oct;64(5):417-419
pubmed: 31543541
J Eur Acad Dermatol Venereol. 2017 Nov;31(11):e492-e493
pubmed: 28502076
Dermatol Surg. 2012 Jul;38(7 Pt 1):1040-6
pubmed: 22455565
J Am Acad Dermatol. 2017 Jul;77(1):136-141.e5
pubmed: 28396101
J Cutan Aesthet Surg. 2016 Jul-Sep;9(3):157-164
pubmed: 27761085
BMJ. 2008 May 10;336(7652):1049-51
pubmed: 18467413
Plast Reconstr Surg Glob Open. 2020 Jun 25;8(6):e2875
pubmed: 32766042
Development. 2009 Oct;136(19):3205-14
pubmed: 19736321
World J Clin Cases. 2017 May 16;5(5):159-171
pubmed: 28560233
Int J Trichology. 2019 May-Jun;11(3):128-131
pubmed: 31360042
J Cosmet Dermatol. 2018 Jun;17(3):423-430
pubmed: 28887865
J Cutan Aesthet Surg. 2014 Oct-Dec;7(4):189-97
pubmed: 25722595
Dermatol Surg. 2016 Nov;42(11):1243-1247
pubmed: 27608205
Clin Oral Investig. 2017 Nov;21(8):2619-2627
pubmed: 28154995
J Dermatolog Treat. 2020 May 26;:1-14
pubmed: 32410524

Auteurs

Aseem Sharma (A)

Chief Dermatologist, Skin Saga Centre for Dermatology, Mumbai, Maharashtra, India.

Kavish Chouhan (K)

Director and Consultant Dermatologist, DERMACLINIX, New Delhi, India.

Satish Bhatia (S)

Director and Consultant Dermatologist, DERMETICS, Mumbai, Maharashtra, India.

Shuken Dashore (S)

Consultant Dermatologist, DHL Skin Centre, Indore, Madhya Pradesh, India.

Classifications MeSH